个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
周二盘中有12只医疗保健类股走势
Gainers
- Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million, which is 824.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.3 billion.
- VYNE Therapeutics (NASDAQ:VYNE) shares rose 22.2% to $1.44. VYNE Therapeutics's stock is trading at a volume of 1.6 million shares as of 12:30 EST. This is 207.52% of its average full-day volume over the last 100 days. The company's market cap stands at $74.2 million.
- Progenity (NASDAQ:PROG) shares increased by 19.82% to $4.05. As of 12:30 EST, this security is trading at a volume of 170.6 million shares, making up 344.38% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $537.5 million.
- Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 19.66% to $0.73. Trading volume for this security as of 12:30 EST is 5.5 million, which is 1189.85% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.9 million.
- Avid Bioservices (NASDAQ:CDMO) shares rose 13.11% to $29.41. Avid Bioservices's stock is trading at a volume of 2.6 million shares as of 12:30 EST. This is 506.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.8 billion.
- Medpace Hldgs (NASDAQ:MEDP) stock moved upwards by 13.08% to $213.03. Trading volume for this security as of 12:30 EST is 455.2K, which is 274.78% of its average full-day volume over the last 100 days. The company's market cap stands at $7.6 billion. The company's, Q3 earnings came out yesterday.
Losers
- Evaxion Biotech (NASDAQ:EVAX) shares declined by 17.05% to $7.01 during Tuesday's regular session. Evaxion Biotech's stock is trading at a volume of 57.2K shares as of 12:30 EST. This is 66.37% of its average full-day volume over the last 100 days. The company's market cap stands at $134.5 million.
- Kiromic BioPharma (NASDAQ:KRBP) stock fell 12.61% to $2.01. Kiromic BioPharma's stock is trading at a volume of 549.2K shares as of 12:30 EST. This is 129.56% of its average full-day volume over the last 100 days. The company's market cap stands at $31.0 million.
- Trevi Therapeutics (NASDAQ:TRVI) shares decreased by 9.03% to $1.21. As of 12:30 EST, this security is trading at a volume of 324.3K shares, making up 89.96% of its average full-day volume over the last 100 days. The company's market cap stands at $29.0 million.
- Myovant Sciences (NYSE:MYOV) shares declined by 7.84% to $19.75. The current volume of 1.3 million shares is 209.58% of Myovant Sciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $1.8 billion. The company's, Q2 earnings came out today.
- Endo International (NASDAQ:ENDP) stock fell 7.84% to $4.35. As of 12:30 EST, Endo International's stock is trading at a volume of 5.1 million, which is 49.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
- Aspira Womens Health (NASDAQ:AWH) stock declined by 7.7% to $3.01. As of 12:30 EST, Aspira Womens Health's stock is trading at a volume of 247.1K, which is 60.38% of its average full-day volume over the last 100 days. The company's market cap stands at $337.2 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
Gainers
赢家
- Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million, which is 824.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.3 billion.
- VYNE Therapeutics (NASDAQ:VYNE) shares rose 22.2% to $1.44. VYNE Therapeutics's stock is trading at a volume of 1.6 million shares as of 12:30 EST. This is 207.52% of its average full-day volume over the last 100 days. The company's market cap stands at $74.2 million.
- Progenity (NASDAQ:PROG) shares increased by 19.82% to $4.05. As of 12:30 EST, this security is trading at a volume of 170.6 million shares, making up 344.38% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $537.5 million.
- Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 19.66% to $0.73. Trading volume for this security as of 12:30 EST is 5.5 million, which is 1189.85% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.9 million.
- Avid Bioservices (NASDAQ:CDMO) shares rose 13.11% to $29.41. Avid Bioservices's stock is trading at a volume of 2.6 million shares as of 12:30 EST. This is 506.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.8 billion.
- Medpace Hldgs (NASDAQ:MEDP) stock moved upwards by 13.08% to $213.03. Trading volume for this security as of 12:30 EST is 455.2K, which is 274.78% of its average full-day volume over the last 100 days. The company's market cap stands at $7.6 billion. The company's, Q3 earnings came out yesterday.
- 奥库根纳斯达克股票代码:OCGN)的股价在周二的例会上上涨了26.44%,至11.81美元。截至美国东部时间12:30,这只证券的成交量为1.356亿美元,是过去100日全天平均成交量的824.79。他们流通股的市值为23亿美元。
- Vyne治疗公司纳斯达克市场代码:Vyne)股价上涨22.2%,至1.44美元。截至美国东部时间12:30,Vyne治疗公司的股票交易量为160万股。这是过去100日平均全天交易量的207.52%。该公司市值为7,420万美元。
- 繁衍生息纳斯达克市场代码:PROG)股价上涨19.82%,至4.05美元。截至美国东部时间中午12点30分,这只证券的成交量为1.706亿股,占其过去100日平均全天成交量的344.38。他们流通股的市值为5.375亿美元。
- Motus Gi Hldgs(纳斯达克股票代码:MOTS)股价上涨19.66%,至0.73美元。截至美国东部时间12:30,该证券成交量为550万,是过去100日全天平均成交量的1189.85。他们流通股的市值为3490万美元。
- 狂热的生物服务纳斯达克股票代码:CDMO)股价上涨13.11%,至29.41美元。截至美国东部时间12:30,Avid Bioservices的股票交易量为260万股。这是过去100日平均全天交易量的506.75%。他们流通股的市值为18亿美元。
- Medpace Hldgs纳斯达克市场代码:MEDP)股价上涨13.08%,至213.03美元。截至美国东部时间12:30,这只证券的成交量为455.2K,是过去100日全天平均成交量的274.78。该公司的市值为76亿美元。该公司第三季度财报昨天出炉。
Losers
失败者
- Evaxion Biotech (NASDAQ:EVAX) shares declined by 17.05% to $7.01 during Tuesday's regular session. Evaxion Biotech's stock is trading at a volume of 57.2K shares as of 12:30 EST. This is 66.37% of its average full-day volume over the last 100 days. The company's market cap stands at $134.5 million.
- Kiromic BioPharma (NASDAQ:KRBP) stock fell 12.61% to $2.01. Kiromic BioPharma's stock is trading at a volume of 549.2K shares as of 12:30 EST. This is 129.56% of its average full-day volume over the last 100 days. The company's market cap stands at $31.0 million.
- Trevi Therapeutics (NASDAQ:TRVI) shares decreased by 9.03% to $1.21. As of 12:30 EST, this security is trading at a volume of 324.3K shares, making up 89.96% of its average full-day volume over the last 100 days. The company's market cap stands at $29.0 million.
- Myovant Sciences (NYSE:MYOV) shares declined by 7.84% to $19.75. The current volume of 1.3 million shares is 209.58% of Myovant Sciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $1.8 billion. The company's, Q2 earnings came out today.
- Endo International (NASDAQ:ENDP) stock fell 7.84% to $4.35. As of 12:30 EST, Endo International's stock is trading at a volume of 5.1 million, which is 49.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
-
Aspira Womens Health (NASDAQ:AWH) stock declined by 7.7% to $3.01. As of 12:30 EST, Aspira Womens Health's stock is trading at a volume of 247.1K, which is 60.38% of its average full-day volume over the last 100 days. The company's market cap stands at $337.2 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
- Evaxion生物技术纳斯达克市场代码:EVAX)股价在周二的例会中下跌17.05%,至7.01美元。截至美国东部时间12:30,Evaxion Biotech的股票交易量为57.2万股。这是过去100天全天平均成交量的66.37%。该公司的市值为1.345亿美元。
- 基洛米克生物制药(Kiroic BioPharma)(纳斯达克市场代码:KRBP)股价下跌12.61%,至2.01美元。截至美国东部时间12:30,Kiroic BioPharma的股票交易量为549.2K股。这是过去100日平均全天交易量的129.56%。该公司的市值为3100万美元。
- 特雷维治疗公司纳斯达克市场代码:TRVI)股价下跌9.03%,至1.21美元。截至美国东部时间12:30,该证券成交量为324.3K股,占其过去100天全天平均成交量的89.96%。该公司的市值为2900万美元。
- Myovant科学(纽约证券交易所代码:MYOV)股价下跌7.84%,至19.75美元。目前130万股的成交量是Myovant Sciences过去100日平均全天成交量的209.58%(最近一次更新是在美国东部时间12:30)。该公司的市值为18亿美元。该公司第二季度财报今天出炉。
- 远藤国际(纳斯达克市场代码:ENDP)股价下跌7.84%,至4.35美元。截至美国东部时间12:30,远藤国际的股票成交量为510万股,是其过去100天全天平均成交量的49.2%。该公司的市值为10亿美元。
-
ASPiRA妇女健康(纳斯达克市场代码:AWH)股价下跌7.7%,至3.01美元。截至美国东部时间12:30,Aspira Women Health的股票成交量为247.1K,是其过去100天全天平均成交量的60.38%。该公司的市值为3.372亿美元。
另见:Www.benzinga.com/money/best-healthcare-stocks/
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!